Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 56Myelodysplastic Syndromes 14Leukemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Recurrence 4Myeloproliferative Disorders 4Leukemia, Myelomonocytic, Chronic 3Leukemia, Monocytic, Acute 3Burkitt Lymphoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Biphenotypic, Acute 2Hematologic Neoplasms 2Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphoid 1Leukemia, Erythroblastic, Acute 1Hodgkin Disease 1Disease 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cytarabine 2venetoclax 1pembrolizumab 1obinutuzumab 1neratinib 1idelalisib 1ibrutinib 1gilteritinib 1Surveys and Questionnaires 1Positron Emission Tomography Computed Tomography 1Mitoxantrone 1Interleukin-15 1Gemtuzumab 1Daunorubicin 1CPX-351 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × CPX-351 × Other hematologic neoplasm × Clear all
NCT00788892 2018-01-12

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Jazz Pharmaceuticals

Phase 2 Completed
126 enrolled 12 charts
Other hematologic neoplasm

Disease, Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡